Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

A novel scoring system integrating molecular abnormalities with IPSS-R can improve the risk stratification in patients with MDS.

BMC cancer - 6 Feb 2021

Gu Siyu, Xia Jingya, Tian Yulu, Zi Jie, Ge Zheng

Abstract excerpt

BACKGROUND: The treatment strategies for Myelodysplastic Syndromes (MDS) are usually based on the risk stratification system. However, few risk signatures which integrate the revised international prognostic scoring system (IPSS-R) with gene mutations can be easily applied in the real world. METHODS: The training cohort of 63 MDS patients was conducted at Zhongda Hospital of Southeast University from January 2013...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Area Under Curve
Share to Dioxygenases
Share to Kaplan-Meier Estimate

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Myelodysplastic Syndromes

Share to Phosphoproteins

Share to Regression Analysis

Share to RNA Splicing Factors

Share to Serine-Arginine Splicing Factors

Source

Open in PubMed Open full text

Identifiers

PMID: 33549060
DOI: 10.1186/s12885-021-07864-y
PMCID: PMC7866647

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-07.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

A novel scoring system integrating molecular abnormalities with IPSS-R can improve the risk stratification in patients with MDS.PMID 33549060Read ↗

Validation of the molecular international prognostic scoring system in patients with myelodysplastic syndromes defined by international consensus classification.Semantic proximity Read ↗

Validation of the Molecular International Prognostic Scoring System in Patients with Myelodysplastic Syndromes Defined by International Consensus ClassificationSemantic proximity Read ↗

Validation of the Molecular International Prognostic Scoring System (IPSS-M) for myelodysplastic neoplasms (MDS) and comparison with the revised International Prognostic Scoring System (IPSS-R) in Chinese Population: A Multicenter Retrospective Study.Semantic proximity Read ↗

When to use which molecular prognostic scoring system in the management of patients with MDS?Semantic proximity Read ↗

Molecular International Prognostic Scoring System for Myelodysplastic Syndromes.Semantic proximity Read ↗

Incorporation of molecular data into the Revised International Prognostic Scoring System in treated patients with myelodysplastic syndromes.Semantic proximity Read ↗

Incorporation of mutations in five genes in the revised International Prognostic Scoring System can improve risk stratification in the patients with myelodysplastic syndrome.Semantic proximity Read ↗

[Molecular international prognostic scoring system for myelodysplastic syndromes].Semantic proximity Read ↗

Molecular landscape of myelodysplastic neoplasms in disease classification and prognostication.Semantic proximity Read ↗

Personalized Prediction Model to Risk Stratify Patients With Myelodysplastic Syndromes.Semantic proximity Read ↗

Incorporating mutations and bone marrow fibrosis into the revised international prognostic scoring system in myelodysplastic syndromes.Semantic proximity Read ↗

Clinico-genetic and prognostic analyses of 716 patients with primary myelodysplastic syndrome and myelodysplastic syndrome/acute myeloid leukemia based on the 2022 International Consensus Classification.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.